Global Clinical Diagnostics Market Projected to Reach USD 150.30 Billion by 2035 – SNS Insider

Rising chronic disease prevalence, AI-powered diagnostics, and growing demand for early detection drive consistent global market growth.

Austin, United States, April 29, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, the Clinical Diagnostics Market was valued at USD 87.99 billion in 2025 and is expected to reach USD 150.30 billion by 2035, growing at a CAGR of 5.50% from 2026-2035. The market for clinical diagnostics is expanding as a result of the growing number of elderly people, the growing prevalence of infectious and chronic diseases, and the growing need for early and accurate diagnosis.

Clinical Diagnostics Market Size & Forecast

• Market Size (2025): USD 87.99 Billion
• Projected Market Size (2035): USD 150.30 Billion
• CAGR (2026–2035): 5.50%
• Forecast Period: 2026–2035
• Base Year: 2025

Get a Sample Report of Clinical Diagnostics Market: https://www.snsinsider.com/sample-request/5675

 The U.S. Clinical Diagnostics Market was valued at USD 26.40 billion in 2025 and is expected to reach USD 45.09 billion by 2035, growing at a CAGR of 5.50% from 2026-2035. The burden of chronic illness, the need for early and precise diagnosis, improvements in molecular and point-of-care testing, and a robust healthcare infrastructure are all contributing factors to the growth of the U.S. clinical diagnostics industry.

Rising Chronic Disease Burden and AI-powered Diagnostic Innovation to Drive Market Growth Globally

When both variables are simultaneously moving in the right direction and more people require more tests, the clinical diagnostics market expands. Diabetes, cardiovascular disease, chronic renal disease, and cancer are among the chronic diseases that are becoming more common globally. Throughout a patient’s course of therapy, these conditions must be continuously monitored through clinical laboratory testing. Liquid biopsy cancer screening, pharmacogenomic testing to match patients to appropriate drug therapies, and multi-analyte point-of-care panels that replace sequences of single tests with simultaneous results are just a few of the test categories that are being created concurrently by new diagnostic technology.

Major Clinical Diagnostics Market Companies Listed in the Report are

• Abbott
• bioMerieux SA
• QuidelOrtho Corporation
• Siemens Healthineers AG
• Bio-Rad Laboratories, Inc.
• Qiagen
• Sysmex Corporation
• Charles River Laboratories
• Quest Diagnostics Incorporated
• Agilent Technologies, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific
• Becton Dickinson and Company
• bioMerieux SA
• Hologic Inc.
• Ortho Clinical Diagnostics
• Luminex Corporation (DiaSorin)
• Myriad Genetics, Inc.
• Guardant Health, Inc.

Segmentation Analysis:

By Test

Infectious Disease Testing held the largest share in the Clinical Diagnostics Market at about 30.6% in 2025 due to rise in infectious disease incidence influenza, tuberculosis, HIV, hepatitis globally. Complete Blood Count testing is expected to grow at the fastest CAGR among test categories due to the growing prevalence of chronic conditions that require CBC monitoring including diabetes-related anemia globally.

By Product

Reagents led the Clinical Diagnostics Market and generated the highest product revenue in 2025 as they are consumed in every test, while instruments are purchased once and maintained for years. Instruments is the fastest-growing product segment, driven by continuous innovation in diagnostic technology.

By End-User

Hospital Laboratories held the dominant end-user share in 2025 as hospitals generate the highest concentration of diagnostic testing events because they serve the sickest patients who require the most comprehensive and urgent diagnostic workups. Point-of-Care Testing is growing the fastest as the healthcare system has compelling structural reasons to want it.

Do you have any specific queries or need any customization research on Clinical Diagnostics Market, make an Enquiry Now: https://www.snsinsider.com/enquiry/5675

Clinical Diagnostics Market Key Segments

By Test

• Lipid Panel
• Liver Panel
• Renal Panel
• Complete Blood Count
• Electrolyte Testing
• Infectious Disease Testing
• Other Tests

By Product

• Instruments
• Reagents
• Other Products

By End User

• Hospital Laboratory
• Diagnostic Laboratory
• Point-of-care Testing
• Other End Users

Regional Insights:

North America led the Clinical Diagnostics Market with the highest share of 35% in 2025, driven by its well-established healthcare infrastructure, high per-capita healthcare expenditure, and heavy emphasis on research and development.

Asia Pacific is growing at a fast pace, fueled by better healthcare infrastructure, rising government expenditure on healthcare, and increasing awareness about early disease detection across the region. 

Recent Developments:

• 2025: Roche launched expanded clinical chemistry test menus for its cobas Pro integrated laboratory system, adding 15 new cardiac biomarker and metabolic tests to the platform’s menu to support hospital laboratories seeking to consolidate testing workflows from multiple platforms onto a single high-throughput analyzer architecture.
• 2025: Abbott received FDA 510(k) clearance for its Alinity i high-sensitivity cardiac troponin assay with improved analytical sensitivity enabling earlier rule-out of acute myocardial infarction within one hour of patient presentation in emergency department settings, representing a significant clinical advancement in time-critical cardiac diagnostic testing.

Exclusive Sections of the Report (The USPs):

• PRICING STRUCTURE & COST ANALYSIS METRICS – helps you understand pricing models, cost components, and benchmarking across routine and specialized diagnostic tests, along with declining cost trends driven by automation.
• TEST VOLUME & UTILIZATION INSIGHTS – helps you evaluate diagnostic demand through annual test volumes, per-capita testing rates, repeat testing patterns, and seasonal fluctuations.
• TECHNOLOGY ADOPTION & INNOVATION METRICS – helps you assess the penetration of molecular diagnostics, immunoassays, point-of-care testing, lab automation, and AI-driven diagnostic solutions.
• LABORATORY INFRASTRUCTURE & CAPACITY UTILIZATION – helps you analyze lab density, hospital vs standalone lab usage, turnaround time efficiency, and overall capacity optimization.
• DISEASE BURDEN & TESTING DEMAND ANALYSIS – helps you identify diagnostic demand across chronic, infectious, oncology, and genetic testing segments, including preventive screening trends.
• HIGH-COMPLEXITY TESTING & REFERENCE LAB INSIGHTS – helps you understand the role of centralized labs, advanced diagnostics, and specialized testing in shaping market growth.

Buy an Enterprise-User PDF of Clinical Diagnostics Market Outlook Report 2026-2035: https://www.snsinsider.com/checkout/5675

Clinical Diagnostics Market Report Scope

Related Market Reports

Molecular Diagnostics Market

Point-of-Care Diagnostics Market

Cancer Diagnostics Market

Infectious Disease Diagnostics Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.